← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2012Last known activity
Sep 22, 2025
Timeline
2000s
- Jun 1, 2007
Spaulding Clinical Research Inc.— Founded
Drugs by trial phase (44 distinct, 34 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (39 own, 0 via acquisition)
Indications
Recent trials (49)
- NCT07176208CollaboratorPhase 1Sep 22, 2025
- NCT07176208OfficialPhase 1Sep 22, 2025
- NCT06192589OfficialPhase 1Feb 8, 2024
- NCT06192589CollaboratorPhase 1Feb 8, 2024
- NCT05906732Overall official - principal investigatorPhase 1/Phase 2Mar 12, 2023
- NCT05470465CollaboratorPhase 1Sep 1, 2022
- NCT05470465Overall official - principal investigatorPhase 1Sep 1, 2022
- NCT05325775Overall official - principal investigatorPhase 1/Phase 2Mar 30, 2022
- NCT05277376Overall official - principal investigatorPhase 3Mar 15, 2022
- NCT05045833CollaboratorPhase 1Oct 18, 2021
- NCT04815993CollaboratorPhase 1Mar 22, 2021
- NCT04815993Overall official - principal investigatorPhase 1Mar 22, 2021
- NCT04764630CollaboratorPhase 1Mar 1, 2021
- NCT04764630Overall official - principal investigatorPhase 1Mar 1, 2021
- NCT04355286CollaboratorPhase 1Jun 30, 2020
Details
- Founded
- West Bend, WI, US Jun 1, 2007
- Last known activity
- Sep 22, 2025
Notes
CRO